AAAAAA

   
Results: 1-20 |
Results: 20

Authors: Engelholm, LH Nielsen, BS Dano, K Behrendt, N
Citation: Lh. Engelholm et al., The urokinase receptor associated protein (uPARAP/Endo180): A novel internalization receptor connected to the plasminogen activation system, TREND CARD, 11(1), 2001, pp. 7-13

Authors: Hoyer-Hansen, G Pessara, U Holm, A Pass, J Weidle, U Dano, K Behrendt, N
Citation: G. Hoyer-hansen et al., Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor, BIOCHEM J, 358, 2001, pp. 673-679

Authors: Nielsen, BS Sehested, M Duun, S Rank, F Timshel, S Rygaard, J Johnsen, M Dano, K
Citation: Bs. Nielsen et al., Urokinase plasminogen activator is localized in stromal cells in ductal breast cancer, LAB INV, 81(11), 2001, pp. 1485-1501

Authors: Engelholm, LH Nielsen, BS Netzel-Arnett, S Solberg, H Chen, XD Garcia, JML Lopez-Otin, C Young, MF Birkedal-Hansen, H Dano, K Lund, LR Behrendt, N Bugge, TH
Citation: Lh. Engelholm et al., The urokinase plasminogen activator receptor-associated Protein/Endo180 iscoexpressed with its interaction partners urokinase plasminogen activator receptor and matrix metalloprotease-13 during osteogenesis, LAB INV, 81(10), 2001, pp. 1403-1414

Authors: Romer, J Pyke, C Lund, LR Ralfkiaer, E Dano, K
Citation: J. Romer et al., Cancer cell expression of urokinase-type plasminogen activator receptor mRNA in squamous cell carcinomas of the skin, J INVES DER, 116(3), 2001, pp. 353-358

Authors: Bajou, K Masson, V Gerard, RD Schmitt, PM Albert, V Praus, M Lund, LR Frandsen, TL Brunner, N Dano, K Fusenig, NE Weidle, U Carmeliet, G Loskutoff, D Collen, D Carmeliet, P Foidart, JM Noel, AS
Citation: K. Bajou et al., The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin: Implications for antiangiogenic strategies, J CELL BIOL, 152(4), 2001, pp. 777-784

Authors: Nielsen, BS Rank, F Lopez, JM Balbin, M Vizoso, F Lund, LR Dano, K Lopez-Otin, C
Citation: Bs. Nielsen et al., Collagenase-3 expression in breast myofibroblasts as a molecular marker oftransition of ductal carcinoma in situ lesions to invasive ductal carcinomas, CANCER RES, 61(19), 2001, pp. 7091-7100

Authors: Ploug, M Ostergaard, S Gardsvoll, H Kovalski, K Holst-Hansen, C Holm, A Ossowski, L Dano, K
Citation: M. Ploug et al., Peptide-derived antagonists of the urokinase receptor. Affinity maturationby combinatorial chemistry, identification of functional epitopes, and inhibitory effect on cancer cell intravasation, BIOCHEM, 40(40), 2001, pp. 12157-12168

Authors: Nielsen, BS Lund, LR Christensen, IJ Johnsen, M Usher, PA Wulf-Andersen, L Frandsen, TL Dano, K Gundersen, HJG
Citation: Bs. Nielsen et al., A precise and efficient stereological method for determining murine lung metastasis volumes, AM J PATH, 158(6), 2001, pp. 1997-2003

Authors: Lund, LR Bjorn, SF Sternlicht, MD Nielsen, BS Solberg, H Usher, PA Osterby, R Christensen, IJ Stephens, RW Bugge, TH Dano, K Werb, Z
Citation: Lr. Lund et al., Lactational competence and involution of the mouse mammary gland require plasminogen, DEVELOPMENT, 127(20), 2000, pp. 4481-4492

Authors: Hoyer-Hansen, G Hamers, MJAG Pedersen, AN Nielsen, HJ Brunner, N Dano, K Stephens, RW
Citation: G. Hoyer-hansen et al., Loss of ELISA specificity due to biotinylation of monoclonal antibodies, J IMMUNOL M, 235(1-2), 2000, pp. 91-99

Authors: Gardsvoll, H Solberg, H Dano, K Hoyer-Hansen, G
Citation: H. Gardsvoll et al., Generation of high-affinity rabbit polyclonal antibodies to the murine urokinase receptor using DNA immunization, J IMMUNOL M, 234(1-2), 2000, pp. 107-116

Authors: Behrendt, N Jensen, ON Engelholm, LH Mortz, E Mann, M Dano, K
Citation: N. Behrendt et al., A urokinase receptor-associated protein with specific collagen binding properties, J BIOL CHEM, 275(3), 2000, pp. 1993-2002

Authors: Pedersen, AN Christensen, IJ Stephens, RW Briand, P Mouridsen, HT Dano, K Brunner, N
Citation: An. Pedersen et al., The complex between urokinase and its type-1 inhibitor in primary breast cancer: Relation to survival, CANCER RES, 60(24), 2000, pp. 6927-6934

Authors: List, K Jensen, ON Bugge, TH Lund, LR Ploug, M Dano, K Behrendt, N
Citation: K. List et al., Plasminogen-independent initiation of the pro-urokinase activation cascadein vivo. Activation of pro-urokinase by glandular kallikrein (mGK-6) in plasminogen-deficient mice, BIOCHEM, 39(3), 2000, pp. 508-515

Authors: Stephens, RW Nielsen, HJ Christensen, IJ Thorlacius-Ussing, O Sorensen, S Dano, K Brunner, N
Citation: Rw. Stephens et al., Plasma urokinase receptor levels in patients with colorectal cancer: Relationship to prognosis, J NAT CANC, 91(10), 1999, pp. 869-874

Authors: Dano, K Romer, J Nielsen, BS Bjorn, S Pyke, C Rygaard, J Lund, LR
Citation: K. Dano et al., Cancer invasion and tissue remodeling - cooperation of protease systems and cell types, APMIS, 107(1), 1999, pp. 120-127

Authors: Lund, LR Romer, J Bugge, TH Nielsen, BS Frandsen, TL Degen, JL Stephens, RW Dano, K
Citation: Lr. Lund et al., Functional overlap between two classes of matrix-degrading proteases in wound healing, EMBO J, 18(17), 1999, pp. 4645-4656

Authors: List, K Hoyer-Hansen, G Ronne, E Dano, K Behrendt, N
Citation: K. List et al., Different mechanisms are involved in the antibody mediated inhibition of ligand binding to the urokinase receptor: a study based on biosensor technology, J IMMUNOL M, 222(1-2), 1999, pp. 125-133

Authors: Gardsvoll, H Dano, K Ploug, M
Citation: H. Gardsvoll et al., Mapping part of the functional epitope for ligand binding on the receptor for urokinase-type plasminogen activator by site-directed mutagenesis, J BIOL CHEM, 274(53), 1999, pp. 37995-38003
Risultati: 1-20 |